At the end of the current inspection, a 'Form 483' was issued with 5 observations which are procedural in nature and no data integrity issues were reported
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Granules India receives 1 observation from USFDA for Chantilly facility
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plants by volume
The company received seven observations in the Form-483
Sun Pharma gets 8 observations from USFDA for Halol facility
The company received one observation in the Form-483
Subscribe To Our Newsletter & Stay Updated
